Surely, Teva needs SOMETHING.BTW, I got out even.Dividend not enoifgh to put up with a dead stock and poor management.IMO.But, GL Teva longs.No sentiment:).Just buy RNN-you NEED something-anything!!!!
"Rexahn Pharmaceuticals announced that it has significantly expanded its intellectual property around a series of novel anti-tumor quinazoline compounds. Rexahn has been issued patent No. 8,404,698 from the U.S. Patent and Trademark Office, covering these novel quinazoline compounds, their pharmaceutical composition, and method for producing an anti-tumor effect."